# Reversing AI drug discovery: Belgian biotech Sightera raises €3M to learn from ‘extreme’ patient biology first

> Source: <https://techfundingnews.com/sightera-raises-3m-extreme-biology-ai-drug-discovery/>
> Published: 2026-07-17 04:00:00+00:00

Most AI drug discovery companies start by selecting a target and designing a molecule, then seeking biological validation.…